|
Volumn 119, Issue 1, 2010, Pages 253-254
|
Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IBANDRONIC ACID;
PAMIDRONIC ACID;
ZOLEDRONIC ACID;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG SURVEILLANCE PROGRAM;
HUMAN;
INCIDENCE;
JAW OSTEONECROSIS;
LETTER;
META ANALYSIS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SYSTEMATIC REVIEW;
TREATMENT DURATION;
BONE DENSITY CONSERVATION AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DATA INTERPRETATION, STATISTICAL;
DIPHOSPHONATES;
FEMALE;
HUMANS;
INCIDENCE;
JAW DISEASES;
OSTEONECROSIS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
EID: 72449165856
PISSN: 01676806
EISSN: 15737217
Source Type: Journal
DOI: 10.1007/s10549-009-0466-2 Document Type: Letter |
Times cited : (4)
|
References (5)
|